• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
OB
CMECNE

Recommended Weight Gain and Obesity Management in Pregnancy

image_pdfFavoriteLoadingFavorite

Learning Objectives and CME/Disclosure Information

This activity is intended for healthcare providers delivering care to women and their families.

After completing this activity, the participant should be better able to:

1. Recall IOM recommendations for target weight gain based on BMI
2. Plan labor management based on obesity criteria

Estimated time to complete activity: 0.25 hours

Faculty:

Susan J. Gross, MD, FRCSC, FACOG, FACMG
President and CEO, The ObG Project

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty: Susan J. Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc.

Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Method of Participation and Request for Credit

Fees for participating and receiving CME credit for this activity are as posted on The ObG Project website. During the period from Dec 31 2017 through Dec 31 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon registering and successfully completing the post-test with a score of 100% and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The ObG Project. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.2 contact hours.

Read Disclaimer & Fine Print

Nutritional counseling is a central element of preconception care and the initial parental visit. The following are the weight gain recommendations, based on the Institute of Medicine (IOM) 2009 guidelines.

IOM Recommendations for Weight Gain in Pregnancy

Singleton pregnancy: 

  • Underweight –  BMI less than 18.5
    • Total weight gain: 28-40 lbs
    • Rate of gain in 2nd & 3rd trimesters: 1 lb/wk
  • Normal weight: BMI between 18.5–24.9
    • Total weight gain: 25-35 lbs
    • Rate of gain in 2nd & 3rd trimesters: 1 lb/wk
  • Overweight:  BMI between 25-29.9
    • Total weight gain: 15-25 lbs
    • Rate of gain in 2nd & 3rd trimesters: 0.6 lb/wk
  • Obesity (all classes, I – III): BMI 30 and greater
    • Total weight gain: 11-20 lbs
    • Rate of gain in 2nd & 3rd gain: 0.5 lb/wk

Twin pregnancy:

  • Normal weight: BMI between 18.5–24.9
    • Total weight gain: 37-54 lbs
    • Rate of gain in 2nd & 3rd trimesters: 1 lb/wk
  • Overweight: BMI between 25-29.9 lbs
    • Total weight gain: 31-50 lbs
    • Rate of gain in 2nd & 3rd trimesters: 0.6 lb/wk
  • Obesity (all classes, I – III): BMI 30 and greater
    • Total weight gain: 25-42 lbs
    • Rate of gain in 2nd & 3rd trimester: 0.5 lb/wk

Perinatal Risks for Not Meeting IOM Weight Gain Targets in Singletons (Goldstein et al., JAMA 2017)

Gestational weight gain below the recommendations

  • Increased risk for SGA (odds ratio [OR], 1.53 [95% CI, 1.44-1.64]; absolute risk difference [ARD], 5% [95% CI, 4%-6%])
  • Increased risk for preterm birth (OR, 1.70 [1.32-2.20]; ARD, 5% [3%-8%]) and
  • Decreased risk for LGA (OR, 0.59 [0.55-0.64]; ARD, -2% [-10% to -6%])
  • Decreased risk for macrosomia (OR, 0.60 [0.52-0.68]; ARD, -2% [-3% to -1%]);
  • No difference for cesarean delivery (OR, 0.98 [0.96-1.02]; ARD, 0% [-2% to 1%])

Gestational weight gain above the recommendations

  • Decreased risk for SGA (OR, 0.66 [0.63-0.69]; ARD, -3%; [-4% to -2%])
  • Decreased risk for preterm birth (OR, 0.77 [0.69-0.86]; ARD, -2% [-2% to -1%])
  • Higher risk of LGA (OR, 1.85 [1.76-1.95]; ARD, 4% [2%-5%])
  • Higher risk for macrosomia (OR, 1.95 [1.79-2.11]; ARD, 6% [4%-9%]),
  • Higher risk for cesarean delivery (OR, 1.30 [1.25-1.35]; ARD, 4% [3%-6%])

SYNOPSIS:

In a systematic review of over 1 million pregnant women, most did not meet the IOM targets, with 47% gaining more and 23% gaining less than IOM recommendations.  ACOG recommends using judgment and individualized care. Medications for weight management are not recommended during the time of conception or during pregnancy. Rather, dietary control, exercise and behavioral modification are the primary weight management strategies during pregnancy.

KEY POINTS:

  • Obese women should be screened early for glucose intolerance and obstructive sleep apnea
  • The optimal control of obesity should begin before conception
    • Weight loss before pregnancy is the most effective intervention to improve medical comorbidities
    • Both nonsurgical and surgical methods prior to pregnancy can have beneficial effects
  • Management in labor and delivery
    • Allow a longer first stage of labor before performing a cesarean section for labor arrest
    • Obtain an early anesthesia consult
    • Consider early epidural placement
    • Consider using a higher preoperative antibiotic dose
    • Closure of the subcutaneous tissue with depth greater than 2 cm can significantly decrease the incidence of wound disruption
    • Consider pharmacologic thromboprophylaxis in addition to pneumatic compression devices for prevention of venous thromboembolism

Learn More – Primary Sources:

ACOG Committee Opinion No. 548: Weight Gain During Pregnancy

IOM: Weight Gain During Pregnancy: Reexamining the Guidelines

ACOG Practice Bulletin No. 156: Obesity in Pregnancy

JAMA: Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis

Take a post-test and get CME credits

TAKE THE POST TEST

Get Guideline Notifications direct to your phone with ObGFirst

Try it Free »

image_pdfFavoriteLoadingFavorite

< Previous
All OB Posts
Next >

Related ObG Topics:

Practical obstetrics info for your women's healthcare practice
Obesity in pregnancy – classification and clinical implications
Does BMI Impact Success of Vacuum-Assisted Vaginal Delivery?
Macrosomia: Determination of EFW and Recommendations for Delivery
Obesity and Stillbirth At Term – What is the Actual Risk?
ACOG Guidance: Antibiotic Prophylaxis during Labor and Delivery
Are Obese Women Less Likely to Have Spontaneous Labor Onset?
Does Elective Induction Lower Risk for Adverse Obstetrical Outcomes in the Setting of Obesity
Is Bariatric Surgery Associated with Decreased Risks for Severe Birth Defects?
Maternal Overweight, Obesity and Congenital Malformations – How Strong is the Link?
NTDs and Pregnancy – Folic Acid Recommendations
Practical obstetrics info for your women's healthcare practice

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site